|
|
Anti-Diabetic
|
| ● |
Gliclaz |
Gliclazide 80mg |
| ● |
Gliclaz - m |
Gliclazide 80mg + Metformin 500mg |
| ● |
Glimchek |
Glimepiride 1 / 2mg |
| ● |
Glimchek - m |
Glimepiride 1 / 2mg Metformin(SR) 500mg |
| ● |
Logit |
Pioglitazone 15 / 30mg |
| ● |
Mpg |
Metformin SR 500 + Pioglitazone 15mg + Glimepiride 1 / 2mg |
| ● |
P&m |
Pioglitazone 15mg + Metformin (ER) 500mg |
| ● |
Roftem-sr |
Metformin SR 500 / 1000mg |
|
|
Present
|
 |
|
Introduced Patented Products based on
NDDS
(Marketed in India and out-Licensed for the
Developing Countries)
|
| |
|
Future
|
 |
|
Patents driven
by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to
the developed countries)
|
| |
|
Anti-Diabetic